Category Archives: Uncategorized

Nabriva Therapeutics has acquired Zavante Therapeutics in a stock deal that brings to the antibiotics developer an FDA-ready drug. Under

We at Xconomy are excited to announce that we are honoring Nancy Hopkins, professor emerita at MIT, with our 2018 Lifetime Achievement

[Source: Research & Innovation] Innovative equipment has been developed to help patients regain control of limbs despite an injury that

Writing last week for Morning Consult, BIO President and CEO Jim Greenwood proposed several policy ideas for Washington lawmakers to

Murdo Gordon, chief commercial officer of Bristol-Myers Squibb (NYSE: BMS), is leaving. The New York-based pharmaceutical giant announced Monday that

Click to view a price quote on ^GSPC.

Drug makers are making more bets on the nascent field of digital medicine. The latest example: Click Therapeutics announced Monday

[Source: Research & Innovation] The final MIME conference on INTERDISCIPLINARITY AND THE FUTURE OF MULTILINGUALISM RESEARCH proposes to discuss the

There’s a huge opportunity to improve agriculture with gene editing. But we need to give CRISPR a chance, writes Tamar

Each year, the Institute of Food Technologists (IFT) holds their annual meeting and expo.  Since 1939, IFT has been bringing the